DNA test may improve depression treatment in cancer patients
NCT ID NCT03674138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether using a person's DNA to pick an antidepressant works better than usual care for cancer patients with depression or anxiety. About 99 adults with cancer took part. Half got a DNA-guided choice of medication, and the other half got standard care. Researchers then compared changes in depression, anxiety, and quality of life between the two groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Virtual reality nature escape may calm fear of childbirth in High-Risk pregnancies
- Can a radioactive tracer reveal whether immunotherapy is working?
- Impostor syndrome among Athlete-Scholars: can sleep and social media play a role?
- Coloring for calm: could mandala art lower stress in High-Risk pregnancy?
- A virtual Walk-Through of radiotherapy may calm cancer Patients' nerves
- Money worries and cancer: can talking about both ease the burden?